Back
Biogen Vs. Neurogene Industry Stock Comparison
Sell
44
BIIB
Biogen
Last Price:
$152.29
Seasonality Move:
3.03%
Sell
4
NGNE
Neurogene
Last Price:
$23.14
Seasonality Move:
11.8%
Sell
44
Biogen (BIIB)
is a Sell
Is Biogen a Buy, Sell or Hold?
-
BIIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NGNE Stock Price Chart
BIIB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.24 | Sell |
Relative Strength Index (14 RSI): | 44.55 | Sell |
Chaikin Money Flow: | 629935 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (148.77 - 158.89) | Sell |
Bollinger Bands (100): | (159.52 - 199) | Sell |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.09 | Sell |
Relative Strength Index (14 RSI): | 43.5 | Sell |
Chaikin Money Flow: | 3326 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.16 - 24.3) | Sell |
Bollinger Bands (100): | (24.3 - 49.48) | Sell |
BIIB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 150.62 | Buy |
20-day SMA: | 151.97 | Buy |
50-day SMA: | 161.92 | Sell |
200-day SMA: | 198.62 | Sell |
8-day EMA: | 150.95 | Buy |
20-day EMA: | 152.8 | Sell |
50-day EMA: | 162.06 | Sell |
200-day EMA: | 194.5 | Sell |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.93 | Buy |
20-day SMA: | 23.03 | Buy |
50-day SMA: | 32.9 | Sell |
200-day SMA: | 37.33 | Sell |
8-day EMA: | 22.96 | Buy |
20-day EMA: | 24.01 | Sell |
50-day EMA: | 29.6 | Sell |
200-day EMA: | 34.08 | Sell |
Biogen Earnings Growth & BIIB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and an increase next year of $0.88 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.00 per share.
Biogen Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |